Generous personal injury coverage on your auto insurance policy may not be enough to cover your medical bills. Patients can get financially blindsided when car and health insurance policies differ.
As a doctor, I was eligible for the COVID-19 vaccine in December, but I also was pregnant, and there wasn't yet much data to inform my decision. What I needed was a different kind of information.
This week’s Medical Minute, discusses the newest gene editing technology, called “prime editing”, that scientists say may be as effective as CRISPR at editing DNA, with less collateral damage.
Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.
A majority of white, rural conservatives in Tennessee are open to getting the vaccine at some point, but at least 45% won't consider it. Rates in Alabama, Georgia and Mississippi are also lagging.
An international team has put human cells into monkey embryos in hopes of finding new ways to produce organs for transplantation. But some ethicists still worry about how such research could go wrong.
COVID-19 vaccines are highly effective but don't always provide perfect protection. Some vaccinated people later exposed to the virus still get sick. Why and how often that happens is under study.
An expert advisory committee to the CDC decided it needed more time to consider whether to recommend the restart administration of the COVID-19 vaccine made by Johnson & Johnson.
Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.
In this week’s Medical Minute, new developments in “cell reprogramming” that could help patients recover from spinal cord injuries which lead to permanent paralysis in the past.
Long-term care options are expensive and often out of reach for elders and people with disabilities. Part of the president's proposed infrastructure plan would help fund home-based health services.
An ear made from an apple, a spinal cord rebuilt using asparagus...it sounds like bizarre science fiction. But Andrew Pelling is working on a way to revive human tissue with a trip to the supermarket.
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.